1,918.50p+38.00 (+2.02%)28 Mar 2024, 18:10
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Hikma Pharmaceuticals PLC Fundamentals

Company NameHikma Pharmaceuticals PLCLast Updated2024-03-28
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue221.885 mMarket Cap£4.26 bn
PE Ratio28.48Dividend per Share$0.62
Dividend Yield2.97Dividend Cover1.37
EPS$0.85EPS Growth (%)0.23
PEG0DPS Growth (%)0.1711
Debt Ratio0.2545Debt Equity Ratio0.4686
Asset Equity Ratio2.1186Cash Equity Ratio0.1037
Quick Ratio0.7603Current Ratio1.57
Price To Book Value2.4432ROCE0

Hikma Pharmaceuticals PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2024-03-212024-05-03USD0.4700
Interim2023-08-102023-09-15GBP0.1988
Prelim2023-03-232023-05-05GBP0.2952
Interim2022-08-182022-09-20GBP0.1600
Prelim2022-03-172022-04-28GBP0.2600
Interim2021-08-192021-09-20GBP0.1300
Prelim2021-03-182021-04-26GBP0.2470

Hikma Pharmaceuticals PLC Company Financials

Assets202320222021
Tangible Assets$1.14 bn$1.08 bn$1.15 bn
Intangible Assets$1.10 bn$1.12 bn$892.00 m
Investments$83.00 m$75.00 m$46.00 m
Total Fixed Assets$2.58 bn$2.47 bn$2.28 bn
Stocks$891.00 m$776.00 m$695.00 m
Debtors$789.00 m$777.00 m$784.00 m
Cash & Equivalents$229.00 m$292.00 m$450.00 m
Other Assets$256.00 m$192.00 m$194.00 m
Total Assets$4.68 bn$4.47 bn$4.37 bn
Liabilities202320222021
Creditors within 1 year$1.34 bn$1.08 bn$1.02 bn
Creditors after 1 year$1.13 bn$1.25 bn$889.00 m
Other Liabilities000
Total Liabilities$2.47 bn$2.32 bn$1.91 bn
Net assets$2.21 bn$2.15 bn$2.47 bn
Equity202320222021
Called up share capital$40.00 m$40.00 m$42.00 m
Share Premium$282.00 m$282.00 m$282.00 m
Profit / Loss$281.00 m$233.00 m$544.00 m
Other Equity$2.20 bn$2.13 bn$2.45 bn
Preference & Minorities$11.00 m$13.00 m$14.00 m
Total Capital Employed$2.21 bn$2.15 bn$2.47 bn
Ratios202320222021
Debt Ratio$0.32$0.35$0.23
Debt-to-Equity$0.47$0.53$0.30
Assets / Equity2.11862.11862.1186
Cash / Equity0.10370.10370.1037
EPS$1.70$1.39$1.75
Cash Flow202320222021
Cash from operating activities$737.00 m$585.00 m$638.00 m
Cashflow before financing$400.00 m$527.00 m$351.00 m
Increase in Cash-$62.00 m-$135.00 m$113.00 m
Income202320222021
Turnover$2.88 bn$2.52 bn$2.55 bn
Cost of sales$1.49 bn$1.28 bn$1.25 bn
Gross Profit$1.39 bn$1.24 bn$1.30 bn
Operating Profit$367.00 m$282.00 m$582.00 m
Pre-Tax profit$281.00 m$233.00 m$544.00 m

Hikma Pharmaceuticals PLC Company Background

SectorHealthcare
ActivitiesHikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
Latest Interim Date3 Aug 2023
Latest Fiscal Year End Date22 Feb 2024

Hikma Pharmaceuticals PLC Directors

AppointedNamePosition
2023-03-16Dr. Pamela Josephine Kirby Non-Executive Director
2024-03-13Mr. Mazen Samih Taleb DarwazahExecutive Director,Vice Chairman
2014-05-15Sir David Kenneth Rowe-Ham GBENon-Executive Director
2017-05-19Mr. Michael Richard Dwyer AshtonNon-Executive Director
2014-05-15Mr. Samih DarwazahNon-Executive Director,Chairman
2024-03-22Mr. Mohammed Ali Khaldoun S Al-HusryNon-Executive Director
2016-05-12Mr. Breffni ByrneNon-Executive Director
2024-03-22Mr. Douglas Michael HurtNon-Executive Director
2018-05-18Dr. Ronald L GoodeNon-Executive Director
2024-03-13Mr. Said DarwazahExecutive Director,Chairman
2022-05-24Mr. Sigurdur O. OlafssonExecutive Director,Chief Executive Officer
2021-03-17Mr. Robert PickeringNon-Executive Director
2024-03-22Ms. Nina HendersonNon-Executive Director
2024-03-22Mr. Patrick ButlerNon-Executive Director
2024-03-22Mr. John Julius CastellaniNon-Executive Director
2024-03-22Ms. Cynthia L. FlowersNon-Executive Director
2024-03-22Dr. Deneen VojtaNon-Executive Director
2024-03-13Mr. Riad MishlawiExecutive Director,Chief Executive Officer

Hikma Pharmaceuticals PLC Contact Details

Company NameHikma Pharmaceuticals PLC
Address1 New Burlington Place, London, W1S 2HR
Telephone+44 2073992760
Websitehttps://www.hikma.com

Hikma Pharmaceuticals PLC Advisors

AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
StockbrokerBank of America Merrill Lynch
Phone+44 2076281000
Fax+44 2078672867
SolicitorAddleshaw Goddard LLP
Phone(020) 7606 8855
Fax(020) 7606 4390
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
StockbrokerCiti
Phone+44 2079864000
Fax+44 2079862266